Apogee Therapeutics, Inc. · NASDAQ:APGE
Wellington Management Group LLP's stake in Apogee Therapeutics, Inc. fell to 0.90% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Jul 8, 2026
Wellington Management Group LLP's stake in Apogee Therapeutics, Inc. fell to 0.90%, 564,326 shares, as a passive investor on Jun 30, 2026. Filed Jul 8, 2026 (Schedule 13G/A).
- Stake
- 0.90%
- Shares
- 564,326
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Wellington Management Group LLP | 0.90% | 564,326 |
| Wellington Group Holdings LLP | 0.90% | 564,326 |
| Wellington Investment Advisors Holdings LLP | 0.90% | 564,326 |
Source
Related
- Apogee Therapeutics, Inc.
- Wellington Management Group LLP
- Apogee Therapeutics, Inc. shareholders
- Schedule 13G/A · Wellington Management Group LLP · Feb 10, 2026
- Schedule 13G/A · Wellington Management Group LLP · Aug 5, 2025
- Schedule 13G/A · Wellington Management Group LLP · Aug 5, 2025
- Schedule 13G/A · Wellington Management Group LLP · May 12, 2025
- Schedule 13D/A · Venrock Healthcare Capital Partners III, L.P. · Sep 8, 2026
- Form 4 · Fairmount Funds Management LLC · Sep 3, 2026
- Form 4 · McKenna Mark C. · Sep 3, 2026
- Form 4 · Jones William A Jr · Sep 3, 2026
- Form 4 · Dambkowski Carl · Sep 3, 2026